When FedEx representatives heard on a conference call that the American Red Cross was aiming to increase the number of African American blood donors by the end of 2025, the company realized it was well-positioned to help.
Southern-based non-profit Women’s Foundation of the South (WFS) is pleased to announce that it is airing the first episode of its four-part Learn with Us series on streaming service Vimeo.
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the addition of a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight™ Oncology (TSO) Comprehensive (EU) test. This single test kit, recently launched across Europe, assesses multiple tumor genes and biomarkers to reveal the specific molecular profile of a patient's cancer.
If we are to avoid system-wide breakdowns in nature, society and the economy, we need to make six great transitions to thriving by turning six forces of breakdown into counterforces of breakthrough, each enabled by significant market opportunities
At the World Economic Forum’s 2022 annual meeting at Davos, Project Last Mile with The Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund) launched its Compendium, Partnering for Health.
In another sign of its commitment to the Austin music industry and its economic impacts, PNC Bank today announced a year-round sponsorship with the Health Alliance for Austin Musicians (HAAM).
Blackstone’s investment in Medable, a leading provider of decentralized clinical trial technology, is helping get effective therapies to more patients.
Abderrahim Oukessou, MD, our vice president and Thoracic Cancers Development Lead, sat down with Adam Schoenfeld, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, to discuss how the landscape of lung cancer research has transformed in recent years.
Illumina, Inc. (NASDAQ: ILMN) a global leader in DNA sequencing and array-based technologies, and Allegheny Health Network (AHN), an integrated health system serving the Western Pennsylvania area, today announced a collaboration to evaluate the impact of in-house comprehensive genomic profiling (CGP) to enhance patient care.
The SCS Kingfisher certification mark is showing up on an increasing number of products around the world. It differentiates companies that are making...
Corporate governance, risk management, operational integrity, and regulatory compliance are demanding challenges that companies face in today’s ever...
Cascale shares updates on its strategic partnerships with industry stakeholders geared toward shifting the industry into one that gives back more than...
